Author

J. M. Lancaster

Observed names: J. Lancaster, J.M Lancaster, J.M. Lancaster

Observed institutions: National Institutes of Health, Duke University, University of South Florida, Moffitt Cancer Center, National Institute of Environmental Health Sciences, Duke Medical Center

OpenAlex ID: A5109920868

Detection of BRCA1 Mutations in Women With Early-Onset Ovarian Cancer by Use of the Protein Truncation Test

1996 · J. M. Lancaster, C. J. Cochran, et al. · JNCI Journal of the National Cancer Institute · 17

Correlation of survival-stratified proteomic and curated gene data reveal a three-protein biomarker panel that predicts long-term survival of patients with primary epithelial ovarian cancer

2014 · K.A. Byrd, N.W. Bateman, et al. · Gynecologic Oncology · 2

Development of a rucaparib response signature that shows in vitro predictive value to the PARP inhibitors, ABT-888 and olaparib in ovarian cancer cells

2014 · S.S. Al Rubaish, Y. Xiong, et al. · Gynecologic Oncology · 1

Identifying drug repurposing opportunities to target genes and molecular pathways associated with cancer cell proliferation

2013 · I. Ramirez, D. Marchion, et al. · Gynecologic Oncology · 1

PLAC1 expression in human cancer cells correlates with carboplatin sensitivity and overall survival from ovarian cancer

2012 · N. Bou Zgheib, Y. Xiong, et al. · Gynecologic Oncology · 1

Patient–provider communication issues concerning fertility preservation with newly diagnosed cancer patients

2008 · S. T. Vadaparampil, G. P. Quinn, et al. · Journal of Clinical Oncology · 1

MicroRNAs that underlie response to salvage chemotherapy in ovarian cancer

2007 · T. P. Boren, S. Cui, et al. · Journal of Clinical Oncology · 1

TGF/Wnt signaling: A metastasis signature for poor-prognosis ovarian cancer

2016 · C. McClung, D. Marchion, et al. · Gynecologic Oncology

PDF

AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome

2015 · D. Marchion, R. Ismail-Khan, et al. · Gynecologic Oncology

Therapeutic dilemma: Prognostic factors and outcome for patients with neuroendocrine tumors of the cervix

2015 · R. Abdallah, Y. Xiong, et al. · Gynecologic Oncology

Molecular signaling pathways associated with squamous-cell carcinoma of the cervix cisplatin-resistance

2015 · B.R. Khulpateea, D. Marchion, et al. · Gynecologic Oncology

Vitamin D suppresses ovarian cancer invasion by inhibiting cytokine expression and NFκB signaling

2015 · P. Lungchukiet, Y. Sun, et al. · Gynecologic Oncology

The BAD apoptotic pathway: A cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival

2015 · S.H. Bush, D. Marchion, et al. · Gynecologic Oncology

AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome

2015 · E. Al Sawah, Y. Xiong, et al. · Gynecologic Oncology

Polyphyllin D, a Chinese herb, potentiates cisplatin-induced death in ovarian cancer cell lines

2014 · E. Al Sawah, D. Marchion, et al. · Gynecologic Oncology

Association between endometrioid endometrial cancer (EC) risk classification and gene expression in The Cancer Genome Atlas (TCGA) dataset

2014 · H.S. Chon, R. Abdallah, et al. · Gynecologic Oncology

A novel cMET inhibitor, MK8033, potentiates the activity of carboplatin/paclitaxel in ovarian cancer cell lines

2013 · D. Marchion, I. Ramirez-Diaz, et al. · Gynecologic Oncology

Characterizing the activity of MK2206 in ovarian cancer and defining the molecular determinants of response

2013 · N. Bou Zgheib, D. Marchion, et al. · Gynecologic Oncology

Common genes and pathways associated with in vitro/in vivo ovarian cancer chemo-response and overall survival

2013 · N. Bou Zgheib, D. Marchion, et al. · Gynecologic Oncology

Molecular determinants for lymph node metastasis in early-stage endometrial cancer

2013 · N. Bou Zgheib, D. Marchion, et al. · Gynecologic Oncology

Pathways involved in doxorubicin sensitivity in vitro correlate with overall survival from ovarian cancer

2013 · N. Bou Zgheib, Y. Xiong, et al. · Gynecologic Oncology

The BAD apoptosis pathway is associated with carcinogenesis in a range of human tissue types

2012 · X. Stickles, D. Marchion, et al. · Gynecologic Oncology

BAD apoptosis pathway expression and survival from cancer

2011 · J. Lancaster, D. Chen, et al. · Gynecologic Oncology

Gene expression determinants of ovarian cancer platinum-response in older women

2008 · J. M. Cragun, T. Boren, et al. · Journal of Clinical Oncology

Characterization of the insulin-like growth factor pathway in endometrial cancers

2005 · J. M. Cragun, A. Elahi, et al. · Journal of Clinical Oncology

Works count: 27

Citation count: 24

H-index: 2

I10-index: 1